The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 12, 24-32
- https://doi.org/10.1111/j.1469-0691.2006.01342.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistanceClinical Microbiology & Infection, 2005
- Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in PennsylvaniaAntimicrobial Agents and Chemotherapy, 2004
- An Outbreak of Community-Onset Methicillin-ResistantStaphylococcus aureusSkin Infections in Southwestern AlaskaInfection Control & Hospital Epidemiology, 2003
- Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance GeneNew England Journal of Medicine, 2003
- Linezolid resistance in clinical isolates of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2002
- Linezolid-resistant enterococci: report of the first isolates in the United KingdomJournal of Antimicrobial Chemotherapy, 2002
- Community-Acquired Methicillin-Resistant Staphylococcus aureus in a Rural American Indian CommunityJAMA, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001